Left ventricular assist devices are becoming an increasingly prevalent therapy for patients
with Stage D heart failure with reduced ejection fraction. Technological advances have …

Cardiogenic shock remains a challenging disease entity and is associated with significant
morbidity and mortality. Temporary mechanical circulatory support (MCS) can be …

Background Right ventricular failure (RVF) increases morbidity and mortality. The
RECOVER RIGHT study evaluated the safety and efficacy of a novel percutaneous right …

Background: Our current understanding of right heart failure (RHF) post-left ventricular assist
device (LVAD) is lacking. Recently, a new Interagency Registry for Mechanically Assisted …

Despite advances in left ventricular assist device (LVAD) technology, right ventricular failure
(RVF) continues to be a complication after implantation. Most patients undergoing LVAD …

Continuous-flow left ventricular assist devices (CF-LVADs) have revolutionized the
management of patients with advanced heart failure. Alternative implant strategies are …

Left ventricular assist devices (LVADs) are common and implantation carries risk of AKI.
LVADs are used as a bridge to heart transplantation or as destination therapy. Patients with …

BACKGROUND: Severe right ventricular failure (RVF) after left ventricular assist device
(LVAD) implantation increases morbidity and mortality. We investigated the association …

Continuous-flow ventricular assist device (cfVAD) performance and patient hemodynamic
conditions are intimately interrelated and dynamic, changing frequently with alterations in …

Background Right heart failure (RHF) is an unresolved issue during continuous-flow left
ventricular assist device (LVAD) support. Little is known about post-transplant outcomes in …